International Journal of Clinical Pediatrics, ISSN 1927-1255 print, 1927-1263 online, Open Access
Article copyright, the authors; Journal compilation copyright, Int J Clin Pediatr and Elmer Press Inc
Journal website http://www.theijcp.org

Case Report

Volume 7, Number 4, December 2018, pages 63-68


A Molecular Study of Solid Pseudopapillary Neoplasm of the Pancreas in a Pediatric Patient

Figures

Figure 1.
Figure 1. (a) Computed tomography image of the abdomen, in the portal phase, showing a rounded and heterogeneous mass in the head of the pancreas, measuring 6.7 cm (transverse) × 6.3 cm (anteroposterior) × 6.4 cm (longitudinal). Areas 1, 2 and 3 are the topographical areas where fresh tissue samples were collected for the molecular study. (b) Transverse section of solid pseudopapillary neoplasm in the head of the pancreas presenting a solid mass with heterogeneous and whitish aspects, associated with blackened hemorrhagic areas. The numbers represent the regions where fresh tissue samples were collected for the molecular study: 1. peripheral; 2. intermediate; and 3. central.
Figure 2.
Figure 2. Hematoxylin and eosin stained slides of solid pseudopapillary neoplasm of the pancreas. (a) Solid pattern with barely cohesive cells presenting ovoid or rounded nuclei, sometimes grooved and eosinophilic cytoplasm. (b) Solid pattern showing cells with clear cytoplasm. (c) Pseudopapillary pattern, with cells distributed around vascular connective axis being the nuclei arranged in apical portion.
Figure 3.
Figure 3. Venn diagram of the identified proteins in the three tumor areas. Only proteins found in two or more technical replicates were considered.
Figure 4.
Figure 4. Immunohistochemistry. (a) Positive β-catenin in the nucleus and cytoplasm. (b) CD99 with perinuclear granular marking (dot). (c) CD10 with irregular positivity in the cytoplasm. (d) CD56 with cytoplasmic membrane positivity. (e) Progesterone receptor, with intranuclear labeling. (f) Ki67 with intranuclear labeling.

Table

Table 1. Comparison Between Immunohistochemical Results and Those Obtained by Mass Spectrometry
 
AntibodyIH/MS
Fragment 1Fragment 2Fragment 3
IH: immunohistochemical analysis; MS: mass spectrometry; NEG: negative; POS: positive; 1, 2 and 3: tumor fragments.
β-cateninPOS/POSPOS/POSPOS/POS
CD99NEG/NEGPOS/POSNEG/NEG
CD10POS/NEGPOS/NEGPOS/NEG
CD56POS/NEGPOS/POSPOS/POS
Chromogranin ANEG/NEGNEG/NEGNEG/NEG
Progesterone receptorPOS/NEGPOS/NEGPOS/NEG
E-cadherinNEG/NEGNEG/POSNEG/POS
SynaptophysinNEG/NEGNEG/POSNEG/POS